Explaining the Avoidance of High-Potency Topical Glucocorticoids on the Face

QUESTION

A patient is on long-term topical high potency glucocorticoid therapy. He asks the nurse why the medication should not be used on the face. Which of the following responses by the nurse would be accurate related to this question? Select all that apply Prolonged use of topical glucocorticoids can lead to atrophy of the dermis and epidermis. Jaundice coloring is likely to develop in the sclera of the eyes if the glucocorticoids are used topically on the face.

ANSWER

Explaining the Avoidance of High-Potency Topical Glucocorticoids on the Face

Introduction

Patients prescribed long-term topical high-potency glucocorticoid therapy may have concerns about the safety and potential side effects of using these medications on their face. To address these concerns, nurses play a crucial role in providing accurate information and guidance. In this essay, we will discuss why high-potency topical glucocorticoids should be avoided on the face and provide accurate responses to the patient’s question.

1. Prolonged Use Can Lead to Atrophy of the Dermis and Epidermis

One of the primary reasons for avoiding the use of high-potency topical glucocorticoids on the face is the risk of skin atrophy. Glucocorticoids can thin the skin over time, leading to fragility and the potential for skin tears.
On the face, where the skin is already thinner and more delicate than on other parts of the body, this risk is heightened. Atrophy of the dermis and epidermis can result in skin that is more prone to bruising and damage.

2. Jaundice Coloring is Likely to Develop in the Sclera of the Eyes if Glucocorticoids are Used Topically on the Face

This statement is not accurate, and the nurse should not provide this as a reason for avoiding topical glucocorticoids on the face.
Jaundice is typically associated with liver dysfunction and is not a side effect of topical glucocorticoid use. Therefore, this response should be corrected to avoid confusion.

Additional Information

It’s important to explain to the patient that the skin on the face is more sensitive and susceptible to adverse effects from potent medications like glucocorticoids.
The risk of developing adverse effects such as telangiectasia (visible blood vessels), perioral dermatitis (a rash around the mouth), and steroid-induced acne is higher when these medications are used on the face.
Alternative treatments or lower-potency topical steroids may be considered for facial skin conditions to minimize the risk of side effects.

Conclusion

In response to the patient’s question about why high-potency topical glucocorticoids should not be used on the face, the nurse should provide accurate information. The primary reason is the risk of skin atrophy, which can make the facial skin more fragile and prone to damage. It is essential to ensure that the information provided is correct and that any misconceptions, such as the development of jaundice coloring in the eyes, are clarified to support the patient’s understanding of their treatment.